Structure-Based Optimization of 10-DEBC Derivatives as Potent and Selective Pim-1 Kinase Inhibitors.
Li, G., Zhang, W., Xie, Y., Li, Y., Cao, R., Zheng, G., Huang, N., Zhou, Y.(2020) J Chem Inf Model 60: 3287-3294
- PubMed: 32407627 
- DOI: https://doi.org/10.1021/acs.jcim.0c00245
- Primary Citation of Related Structures:  
6KZI, 6L11, 6L12, 6L13, 6L14, 6L15, 6L16, 6L17 - PubMed Abstract: 
Pim-1 kinase has been widely regarded as an attractive target for anticancer drugs. Here, we reported our continued efforts in structure-based optimization of compound 10-DEBC, a previously identified micromolar Pim-1 inhibitor. Guided by the Site Identification by Ligand Competitive Saturation (SILCS) method, we quickly obtained a series of 10-DEBC derivatives with significantly improved activity and selectivity. In particular, compound 26 exhibited an IC 50 value of 0.9 nM, as well as 220- and 8-fold selectivity over Pim-2 and Pim-3 kinases, respectively.
Organizational Affiliation: 
State Key Laboratory of Chemical Resources Engineering, Beijing University of Chemical Technology, Beijing 100029, China.